Publication:
Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.

dc.contributor.authorBallestero-Tellez, M
dc.contributor.authorDocobo-Perez, F
dc.contributor.authorRodriguez-Martinez, J M
dc.contributor.authorConejo, M C
dc.contributor.authorRamos-Guelfo, M S
dc.contributor.authorBlazquez, J
dc.contributor.authorRodriguez-Baño, J
dc.contributor.authorPascual, A
dc.contributor.funderMinisterio de Economía y Competitividad, Instituto de Salud Carlos III
dc.contributor.funderConsejería de Salud, Junta de Andalucía
dc.contributor.funderSpanish Network for Research in Infectious Diseases
dc.date.accessioned2023-01-25T09:42:54Z
dc.date.available2023-01-25T09:42:54Z
dc.date.issued2017-01-03
dc.description.abstractFosfomycin is re-evaluated as a treatment of multidrug-resistant Enterobacteriaceae infections. However, MIC differences have been described among the different susceptibility testing. The aim was to study the role of the different inoculum size used in agar dilution with respect to broth microdilution, according to CLSI, in the fosfomycin MIC discrepancies. Fosfomycin MICs were determined using agar dilution (reference) and broth microdilution in 220 Escherichia coli (n=81) and Klebsiella pneumoniae (n=139) clinical isolates. Fosfomycin mutant frequencies were determined in 21 E. coli (MIC=1mg/L) and 21 K. pneumoniae (MIC=16mg/L). The emergence of resistant subpopulations of five E. coli strains (MIC=1mg/L) was monitored over the time by microdilution assay using 0, 4 and 8 mg/L of fosfomycin, and eight different inocula (5×105-3.91×103 CFU/well, 1 : 2 dilutions). For E. coli, 86.4% of categorical agreement (CA), 9.1% very major errors (VME), 3.3% major errors (ME) and 9.9% minor errors (mE) were found. For K. pneumoniae, CA was 51.1%, VME 15.7%, ME 28.4% and mE 25.2%. Essential agreement (±1-log2) was observed in 55.45%. By microdilution, 35.9% of the MICs showed discrepancies of ≥2 dilutions. Initial inoculum used was 5.63 times higher in the microdilution method, in range with CLSI methodology for both techniques. Fosfomycin mutant frequencies were 6.05×10-5 (4×MIC) to 5.59×10-7 (256×MIC) for E. coli, and 1.49×10-4 (4×MIC) to 1.58×10-5 (16×MIC) for K. pneumoniae. Resistant subpopulations arose mainly after 8 h of incubation with inocula >3.13×104 CFU/well. The higher inoculum used in the microdilution method enriched the initial inoculum with resistant subpopulations and could partially explain the fosfomycin MIC discrepancies with respect to the agar dilution method.
dc.description.sponsorshipThis work was supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III (PI13/01885 and PI13/01282) and the Consejería de Salud, Junta de Andalucía (PI-0044-2013), Spain. It was partially supported by Plan Nacional de I+D+i and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF. Fernando Docobo-Pérez is supported by a VPPI-US fellowship from the University of Sevilla.
dc.description.versionSi
dc.identifier.citationBallestero-Téllez M, Docobo-Pérez F, Rodríguez-Martínez JM, Conejo MC, Ramos-Guelfo MS, Blázquez J, et al. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. Clin Microbiol Infect. 2017 May;23(5):325-331.
dc.identifier.doi10.1016/j.cmi.2016.12.022
dc.identifier.essn1469-0691
dc.identifier.pmid28062317
dc.identifier.unpaywallURLhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X16306541/pdf
dc.identifier.urihttp://hdl.handle.net/10668/10750
dc.issue.number5
dc.journal.titleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
dc.journal.titleabbreviationClin Microbiol Infect
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.page.number325-331
dc.provenanceRealizada la curación de contenido 09/07/2025.
dc.pubmedtypeJournal Article
dc.relation.projectIDREIPI RD12/0015
dc.relation.projectIDPI-0044-2013
dc.relation.projectIDPI13/01885
dc.relation.projectIDPI13/01282
dc.relation.publisherversionhttps://linkinghub.elsevier.com/retrieve/pii/S1198-743X(16)30654-1
dc.rights.accessRightsRestricted Access
dc.subjectBacterial subpopulation
dc.subjectFosfomycin
dc.subjectHeteroresistance
dc.subjectMutant frequency
dc.subjectSusceptibility test
dc.subject.decsEscherichia coli
dc.subject.decsPruebas de sensibilidad microbiana
dc.subject.decsFosfomicina
dc.subject.decsInfecciones por Escherichia coli
dc.subject.decsKlebsiella pneumoniae
dc.subject.decsPruebas antimicrobianas de difusión por disco
dc.subject.meshAgar
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshCulture Media
dc.subject.meshDrug Resistance, Multiple, Bacterial
dc.subject.meshEnterobacteriaceae
dc.subject.meshEscherichia coli
dc.subject.meshFosfomycin
dc.subject.meshKlebsiella pneumoniae
dc.subject.meshMicrobial Sensitivity Tests
dc.titleRole of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number23
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format